ArticleJAC-antimicrobial resistance2025

Aztreonam-avibactam for the treatment of serious infections caused by metallo-β-lactamase-producing Gram-negative pathogens: a Phase 3 randomized trial (ASSEMBLE).

George L Daikos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.